DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,438 | -20.1% | 296 | -22.7% | 0.01% | -12.5% |
| Q2 2023 | $91,920 | -58.8% | 383 | -56.7% | 0.01% | -60.0% |
| Q1 2023 | $223,056 | +127.7% | 885 | +139.8% | 0.02% | +122.2% |
| Q4 2022 | $97,939 | +4.2% | 369 | +1.9% | 0.01% | -10.0% |
| Q3 2022 | $94,000 | +9.3% | 362 | +7.1% | 0.01% | +11.1% |
| Q2 2022 | $86,000 | -13.1% | 338 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $99,000 | -10.8% | 338 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $111,000 | +7.8% | 338 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $103,000 | +13.2% | 338 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $91,000 | +68.5% | 338 | +42.0% | 0.01% | +50.0% |
| Q1 2021 | $54,000 | +22.7% | 238 | +20.2% | 0.01% | 0.0% |
| Q4 2020 | $44,000 | +2.3% | 198 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $43,000 | +79.2% | 198 | +48.9% | 0.01% | +75.0% |
| Q2 2020 | $24,000 | +33.3% | 133 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $18,000 | -14.3% | 133 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $21,000 | +10.5% | 133 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $19,000 | -74.0% | 133 | -74.1% | 0.00% | -71.4% |
| Q2 2019 | $73,000 | +7.4% | 513 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $68,000 | +28.3% | 513 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $53,000 | -5.4% | 513 | 0.0% | 0.01% | +9.1% |
| Q3 2018 | $56,000 | +9.8% | 513 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $51,000 | 0.0% | 513 | 0.0% | 0.01% | -8.3% |
| Q1 2018 | $51,000 | +15.9% | 513 | +10.6% | 0.01% | +20.0% |
| Q4 2017 | $44,000 | +12.8% | 464 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $39,000 | 0.0% | 464 | 0.0% | 0.01% | -9.1% |
| Q2 2017 | $39,000 | 0.0% | 464 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $39,000 | +457.1% | 464 | +452.4% | 0.01% | +450.0% |
| Q4 2016 | $7,000 | 0.0% | 84 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $7,000 | 0.0% | 84 | +13.5% | 0.00% | -33.3% |
| Q2 2016 | $7,000 | 0.0% | 74 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $7,000 | +133.3% | 74 | +117.6% | 0.00% | +200.0% |
| Q4 2015 | $3,000 | +200.0% | 34 | +142.9% | 0.00% | 0.0% |
| Q3 2015 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -99.5% | 14 | -99.4% | 0.00% | -100.0% |
| Q1 2015 | $206,000 | -4.2% | 2,514 | 0.0% | 0.10% | -14.4% |
| Q4 2014 | $215,000 | +21400.0% | 2,514 | +17857.1% | 0.11% | +11000.0% |
| Q3 2014 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |